PINK1 and Parkin regulate IP₃R-mediated ER calcium release

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Defects in intracellular calcium homeostasis are implicated in Parkinson's disease (PD) pathogenesis.
• The precise molecular mechanisms linking calcium dysregulation to PD remain largely unknown.

Purpose of the Study:

• To elucidate the role of PTEN-induced kinase 1 (PINK1) and Parkin in regulating intracellular calcium homeostasis.
• To identify molecular players involved in calcium dysregulation in PD.

Main Methods:

• Investigated the effects of PINK1 and Parkin loss on ER calcium release in mammalian cells and Drosophila models.
• Utilized genetic and pharmacologic approaches to modulate CISD1/Dosmit activity.
• Assessed PD-related phenotypes in Drosophila, including locomotor activity and dopaminergic neurodegeneration.

Main Results:

• Loss of PINK1 and Parkin leads to increased ER calcium release due to dysregulated inositol 1,4,5-trisphosphate receptor (IP3R) activity.
• CDGSH iron sulfur domain 1 (CISD1) was identified as a downstream effector of Parkin, directly controlling IP3R.
• Suppression of CISD1/Dosmit restored normal calcium homeostasis and rescued PD-related phenotypes in both cell and fly models, indicating an evolutionarily conserved mechanism.

Conclusions:

• The PINK1-Parkin pathway regulates intracellular calcium homeostasis through CISD1 and IP3R.
• Targeting the CISD1-IP3R interaction offers a potential therapeutic strategy for Parkinson's disease.